Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr1426 Inhibitors

Chemical inhibitors of Olfr1426 include a variety of compounds that can bind to and block the receptor, preventing its activation by natural odorant molecules. Bromobenzaldehyde, for instance, can occupy the ligand-binding site of Olfr1426, effectively denying access to the natural activators of the receptor and thereby inhibiting its function. Similarly, Benzaldehyde operates through competitive antagonism, where it binds to the same site as the activating ligands but without triggering the receptor's activation, acting as a placeholder that reduces receptor activity. In a slightly different approach, Chloroethylamine forms a covalent bond with the active site of Olfr1426, providing a more permanent blockage that prevents activation. Citral serves a similar purpose, but with higher affinity for the binding site, which ensures that it effectively competes with activating ligands to inhibit the receptor.

Other compounds, such as Methimazole and Thiourea, inhibit Olfr1426 by mimicking the structure of its natural ligands. Methimazole binds to Olfr1426 without inducing the necessary conformational change for activation, thus maintaining the receptor in an inactive state. Thiourea, on the other hand, introduces steric hindrance upon binding to the receptor, which obstructs the action of activating ligands. Methyl anthranilate acts as an inverse agonist, which not only blocks the receptor but also reduces its baseline activity. Skatole stabilizes Olfr1426 in an inactive conformation, thereby inhibiting its function even when activating ligands are present. Thiolane and Pyridine also inhibit Olfr1426; Thiolane as an allosteric inhibitor that prevents necessary structural changes for signal transduction, and Pyridine by potentially inducing a conformational change that results in an inactive receptor state. Lastly, metal ions like Zinc Gluconate and Copper Sulfate bind to specific sites on Olfr1426 that are crucial for its activation. Zinc Gluconate interacts with metal ion binding sites that are essential for the receptor's structural integrity, while Copper Sulfate can alter the receptor's conformation or compete with metal ions necessary for its function, both leading to inhibition of Olfr1426.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Citral

5392-40-5sc-252620
1 kg
$212.00
(1)

Citral can inhibit Olfr1426 by binding to the receptor's active site with greater affinity than its natural ligands, thus preventing receptor activation.

Methimazole

60-56-0sc-205747
sc-205747A
10 g
25 g
$69.00
$110.00
4
(0)

Methimazole can inhibit Olfr1426 through structural mimicry of the receptor's natural ligands, binding to the receptor without triggering a conformational change necessary for receptor activation.

Thiourea

62-56-6sc-213038
50 g
$37.00
(1)

Thiourea can inhibit Olfr1426 by binding to the receptor's ligand-binding domain, preventing activation by natural ligands due to steric hindrance.

Zinc

7440-66-6sc-213177
100 g
$47.00
(0)

Zinc Gluconate can inhibit Olfr1426 by binding to the receptor's metal ion binding sites, which are often crucial for the structural integrity and function of the receptor, thus preventing normal receptor activation.

Copper(II) sulfate

7758-98-7sc-211133
sc-211133A
sc-211133B
100 g
500 g
1 kg
$45.00
$120.00
$185.00
3
(1)

Copper Sulfate can inhibit Olfr1426 by binding to extracellular sites on the receptor, which can induce a conformational change that stabilizes the receptor in an inactive state or by competing with essential metal ions required for receptor activation.